24 Feb Update: SAHPRA and the SputnikV Vaccine
Posted at 10:11h in Press Releases
24 February 2021
SAHPRA has received documentation for the SputnikV vaccine developed by the Gamaleya Institute in Russia on 24 February 2021.
SAHPRA will now commence with evaluating the data provided for safety, quality and efficacy of the vaccine.